TUBERCULOSIS ELIMINATION BY 2025 – IS IT ACHIEVABLE OR OVERAMBITIOUS?
DOI:
https://doi.org/10.55489/njmr.12012022892Keywords:
Tuberculosis, Elimination, achievable, overambitiousAbstract
NA
References
Koch R - Die Ätiologie der Tuberkulose, In: J. Schwalbe (Ed.). Gesammelte Werke von Robert Koch, Verlag von Georg Thieme, Leipzig, 1882; 1: 428-45.
Patel RV, Riyaz SD, Park SW - Bedaquiline: a new hope to treat multi-drug resistant tuberculosis. Curr Top Med Chem 2014; 14 (16): 1866-74. Doi: https://doi.org/10.2174/1568026614666140929114822 PMid:25262806
WHO - Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization, 2010. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf (accessed Aug 18, 2010),
Kant S, Maurya AK, Kushwaha RAS, Nag VL, Prasad R Multi-drug resistant tuberculosis: An iatrogenic problem. Bio Science Trends 2010; 4(2): 39-47. 48-55.
Nutritional Support to TB patients (NikshayPoshan Yojana). Available from URL: https://tbcindia.gov.in/showfile.php?lid=3318. Last accessed 2018 on May 19,
WHO Delhi TB Summit: WHO South-East Asia countries commit to intensified efforts, concrete progress to End TB https://www.who.int/southeastasia/news/detail/13-03-2018delhi-tb-summit-who-south-east-asia-countries-commit-to-intensified-efforts-concrete-progress-to-end-tb.
Revised National Tuberculosis Control Programme National Strategic Plan for Tuberculosis Elimination 2017-2025. Available on: https:/71bcindia.gov.in/WriteReadData/NSP%20Draft%2020.02.2017%201.pdf
WHO Global Report on The End TB Strategy. Available on https://www.who.int/tb/post2015_strategy/en/
Narain A, Verma AK, Srivastava A, Kant S-Drug Resistance Pattern in the Clinical Isolates of Pulmonary Tuberculosis. Acta Scientific Microbiology 2019: 2(10): 66-73. Doi: https://doi.org/10.31080/ASMI.2019.02.0374
Government of India Ministry of Health and Family Welfare Nirman Bhavan, New Delhi, D.O.No. A. 66013/34/30.12.2019-TB.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Author/s retain the copyright of their article, with first publication rights granted to Medsci Publications.
